Collagen Matrix announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Flexible Collagen Nerve Conduit.
The conduit — a resorbable, flexible type I collagen tubular matrix — is intended for management of peripheral nerve injuries at nerve ends in the foot to reduce the formation of painful neuroma. It aims at helping people suffering from pain as a result of conditions such as Morton's neuroma affecting the ball of the foot.
Collagen Matrix is a provider of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws